Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arne Strauß

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
BMC Urology|June 22, 2013
Laser-supported partial laparoscopic nephrectomy for renal cell carcinoma without ischaemia timeHagen Loertzer, Arne Strauß, Rolf Herrmann Ringert, et al.
Future Oncology (London, England)|December 4, 2020
Toxicities of axitinib, sunitinib and temsirolimus: implications for progression-free and overall survival in metastatic renal cell cancerAnnemarie Uhlig, Johannes Uhlig, Lutz Trojan, et al.
Springerplus|October 22, 2014
Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC)Felix Bremmer, Hubertus Jarry, Arne Strauß, et al.
The World Journal of Men'S Health|February 4, 2024
Personalized Treatment Strategy in "Low-Risk Prostate Cancer Active Surveillance Candidates" Using Irreversible Electroporation: Prospective Evaluation of Feasibility, Morbidity, Functional and Oncological OutcomesIonel Valentin Popeneciu, Mirjam Naomi Mohr, Arne Strauß, et al.
Urologie (Heidelberg, Germany)|October 10, 2025
[Devastating course-good outcome! Excellent results thanks to artificial urinary sphincter implantation despite perineal urethrostomy-a case report]Niklas Matthias Bohne, Roberto Olianas, Arne Strauß, et al.
Cancers|July 27, 2022
The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer-A Practical Clinical ReviewAnna Rebecca Lisney, Conrad Leitsmann, Arne Strauß, et al.
Frontiers in Immunology|May 14, 2023
Study protocol: a prospective single-center study for non-invasive biomonitoring of renal complications in cancer patients treated with immune checkpoint inhibitorsEva Baier, Peter Korsten, Arne Strauß, et al.
Clinical Genitourinary Cancer|November 6, 2025
Real-World Experience With Lenvatinib Plus Everolimus (LEN+EVE) in Patients With Pretreated Advanced Renal Cell Carcinoma (RELEVANCE): A Retrospective, Multicenter Case SeriesHendrik Eggers, Ramona Stelmacher, Martin Bögemann, et al.
Urology Annals|June 12, 2023
Prospective evaluation of an intraoperative urodynamic stress test predicting urinary incontinence after robot-assisted laparoscopic radical prostatectomyMirjam Naomi Mohr, Annemarie Uhlig, Arne Strauß, et al.
BMC Urology|September 2, 2025
Combined robot-assisted surgery of upper and lower genitourinary tract with excellent early functional and oncological outcome - a case report of a concomitant nerve-sparing radical prostatectomy, diverticulectomy and ureterectomyJan Lüdecke, Mirjam Naomi Mohr, Till Rasmus Schneider, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
BMC Urology|June 22, 2013
Laser-supported partial laparoscopic nephrectomy for renal cell carcinoma without ischaemia timeHagen Loertzer, Arne Strauß, Rolf Herrmann Ringert, et al.
Future Oncology (London, England)|December 4, 2020
Toxicities of axitinib, sunitinib and temsirolimus: implications for progression-free and overall survival in metastatic renal cell cancerAnnemarie Uhlig, Johannes Uhlig, Lutz Trojan, et al.
Springerplus|October 22, 2014
Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC)Felix Bremmer, Hubertus Jarry, Arne Strauß, et al.
The World Journal of Men'S Health|February 4, 2024
Personalized Treatment Strategy in "Low-Risk Prostate Cancer Active Surveillance Candidates" Using Irreversible Electroporation: Prospective Evaluation of Feasibility, Morbidity, Functional and Oncological OutcomesIonel Valentin Popeneciu, Mirjam Naomi Mohr, Arne Strauß, et al.
Urologie (Heidelberg, Germany)|October 10, 2025
[Devastating course-good outcome! Excellent results thanks to artificial urinary sphincter implantation despite perineal urethrostomy-a case report]Niklas Matthias Bohne, Roberto Olianas, Arne Strauß, et al.
Cancers|July 27, 2022
The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer-A Practical Clinical ReviewAnna Rebecca Lisney, Conrad Leitsmann, Arne Strauß, et al.
Frontiers in Immunology|May 14, 2023
Study protocol: a prospective single-center study for non-invasive biomonitoring of renal complications in cancer patients treated with immune checkpoint inhibitorsEva Baier, Peter Korsten, Arne Strauß, et al.
Clinical Genitourinary Cancer|November 6, 2025
Real-World Experience With Lenvatinib Plus Everolimus (LEN+EVE) in Patients With Pretreated Advanced Renal Cell Carcinoma (RELEVANCE): A Retrospective, Multicenter Case SeriesHendrik Eggers, Ramona Stelmacher, Martin Bögemann, et al.
Urology Annals|June 12, 2023
Prospective evaluation of an intraoperative urodynamic stress test predicting urinary incontinence after robot-assisted laparoscopic radical prostatectomyMirjam Naomi Mohr, Annemarie Uhlig, Arne Strauß, et al.
BMC Urology|September 2, 2025
Combined robot-assisted surgery of upper and lower genitourinary tract with excellent early functional and oncological outcome - a case report of a concomitant nerve-sparing radical prostatectomy, diverticulectomy and ureterectomyJan Lüdecke, Mirjam Naomi Mohr, Till Rasmus Schneider, et al.
Pageof 2